| Literature DB >> 18194574 |
Carlos Cotrim1, Ana G Almeida, Manuel Carrageta.
Abstract
BACKGROUND: The development of intra-ventricular gradients (IVG) during dobutamine or exercise stress is not infrequent, and can be associated to symptoms during stress. The purpose of this study was to assess the occurrence of IVG during exercise stress echocardiography in cardiac syndrome X patients.Entities:
Mesh:
Year: 2008 PMID: 18194574 PMCID: PMC2253520 DOI: 10.1186/1476-7120-6-3
Source DB: PubMed Journal: Cardiovasc Ultrasound ISSN: 1476-7120 Impact factor: 2.062
Figure 1A line that originates at the point where the inferior wall begins, divides the left ventricle in halfs. The D1 distance is the distance between that line and the postero internal papillary muscle (arrow) at the point where it encounters the inferior wall.
Figure 2In this apical four chamber view obtained near peak exercise (before stoping) we can clearly see systolic anterior movement of mitral valve.
Figure 3The flow obtained at that moment with continuous Doppler.
Figure 4Summary of a positive exercise stress test in one patient from the study.
Figure 5Normal angiography of coronary arteries in the same patient.
Clinical and demographic data
| Group A | Group B | p | |
| Age, years | 47,70 ± 13,36 | 53,53 ± 10,89 | 0,026 |
| Sex, female (%) | 10/33 (30%) | 34/58 (59%) | 0,008 |
| BSA m2 | 1,8 ± 0,16 | 1,73 ± 0,13 | 0,022 |
| Effort Angina | 28/33 (85%) | 33/58 (56%) | 0,006 |
| Effortless Angina | 9/33 (27%) | 35/58 (57%) | 0,002 |
| Duration of symptoms before cath. (months) | 15 ± 10 | 46 ± 40 | 0,000 |
| Time of FLW (months) | 36,4 ± 17,9 | 39,1 ± 19,5 | 0,55 |
| Events in FLW | 6/33 (18%) | 8/56 (14%) | 0,31 |
| ACS in FLW | 1/33 (3%) | 7/56 (13%) | 0,24 |
| β Bloq. | 7/33 (21%) | 11/58 (19%) | 0,798 |
| CCB | 4/33 (12%) | 7/58 (12%) | 0,666 |
| Nitrates | 16/33 (48%) | 31/58 (53%) | 0,769 |
| IECA/ARAII | 5/33 (15%) | 7/58 (12%) | 0,680 |
| Diuretics | 2/33 (6%) | 5/58 (9%) | 0,663 |
| β Bloq. FLW | 20/33 (60%) | 17/56 (30%) | 0,003 |
| CCB FLW | 4/33(12%) | 19/56 (34%) | 0,530 |
| Nitrates FLW | 9/33 (27%) | 33/56 (59%) | 0,006 |
| IECA/ARAII FLW | 9/33 (27%) | 8/56 (14%) | 0,068 |
| Diuretics FLW | 4/33(12%) | 4/56 (7%) | 0,403 |
BSA – body surface area; ACS – Acute coronary Syndrome; CCB – Calcium chanell blockers; FLW – follow-up
Exercise test data
| Group A | Group B | p | |
| HR Baseline | 70 ± 10,5 | 70 ± 11 | 0,769 |
| HR Peak | 163 ± 14 | 151 ± 17 | 0,001 |
| Syst. BP Baseline | 133 ± 13 | 135 ± 15 | 0,575 |
| Syst. BP Peak | 175 ± 21 | 173 ± 27 | 0,640 |
| %theoretical MHR | 95 ± 7 | 91 ± 9 | 0,02 |
| Duration seconds | 659 ± 159 | 503 ± 175 | 0,000 |
| Time recovery HR | 254 ± 99 | 260 ± 151 | 0,832 |
| Double product | 28760 ± 4493 | 26232 ± 4760 | 0,015 |
| Angina during ESE | 22/33 (66%) | 20/58(34%) | 0,002 |
HR – heart rate; BP – blood pressure; MHR – maxymal heart rate.
Details of echocardiogram M Mode
| Group A | Group B | p | |
| LVEDDi (mm/m2) | 25,3 ± 2,8 | 28 ± 2,7 | 0,000 |
| LVESDi | 15,6 ± 2,4 | 17,4 ± 2,3 | 0,0002 |
| FS (%) | 38,9 ± 5,4 | 37,5 ± 4,9 | 0,219 |
| IVSi (mm/m2) | 5,2 ± 0,9 | 5,1 ± 0,8 | 0,62 |
| PWi (mm/m2) | 4,55 ± 0,7 | 4,59 ± 0,6 | 0,75 |
| LVMi g/m2 | 73,9 ± 13,1 | 80,6 ± 13,9 | 0,028 |
| LA (mm) | 37,1 ± 3,2 | 37,8 ± 2,7 | 0,279 |
| RLVWT | 0,36 ± 0,068 | 0,33 ± 0,046 | 0,01 |
LVEDDi – left ventricle telediastolic diameter index; LVESDi – left ventricle telesystolic diameter index; FS – fraccional shortening; IVSi – interventricular septum index; PWi – posterior wall index; LVMi – left ventricular mass index; LA – left atrium; RLVWT – relative left ventricular wall thickness
Details of two-dimensional echocardiogram
| Group A | Group B | p | |
| LVOTi (mm/m2) | 10,29 ± 0,9 | 11,4 ± 1 | 0,000 |
| EF (%) | 67,94 ± 5,4 | 66,90 ± 4,5 | 0,333 |
| LVDVi ml/m2 | 44,8 ± 10 | 56 ± 11,6 | 0,000 |
| D1 (mm) | 10,72 ± 3,11 | 13,75 ± 2,98 | 0,000 |
LVOTi – left ventricular outflow tract index; EF – ejection fraction, LVDVi – left ventricular diastolic volume index; D1 – distance D1 measured as explained in figure 1.
Details of echocardiogram (Doppler)
| Group A | Group B | p | |
| CiLLD ml/m2 | 2086 ± 561 | 2235 ± 495 | 0,198 |
| CWmáxLLD cms | 130 ± 15,8 | 120,6 ± 12,5 | 0,002 |
| CWmáxOrtho cms | 117 ± 14 | 111 ± 12 | 0,027 |
| CWmáx 3 | 182 ± 15 | 158 ± 15 | 0,000 |
| E cms | 85 ± 14 | 85 ± 16 | 0,963 |
| A cms | 68 ± 19 | 67 ± 13 | 0,772 |
| Dec. time sec. | 170 ± 34 | 175 ± 44 | 0,614 |
| IVRT | 85,9 ± 15 | 88,9 ± 11 | 0,286 |
| PV | 50 ± 12,8 | 47,9 ± 9,8 | 0,314 |
CiLLD – cardiac index in left lateral decubitus before de start of the exam; CWmáxLLD – máximal velocity of flow obtained at apical five chamber view with continuous Doppler oriented through LVOT to the aorta in left lateral decubitus; CwmáxOrtho – máximal velocity of flow obtained at apical five chamber view with continuous Doppler oriented through LVOT to the aorta in orthostatic position; CWmáx3-máximal velocity of flow obtained at apical five chamber view with continuous Doppler oriented through LVOT to the aorta; E- maximal velocity of E wave of mitral flow; A – maximal velocity of E wave of mitral flow; Dec. Time sec.- deceleration time in seconds; IRVT – isovolumic relaxation time; PV propagation of velocity evaluated with M Mode color.
Multivariate analysis
| Variable | -2 Log Likelihood | Loss Function (p) |
| Age | 114,1548 | ,071918 |
| Sex | 109,0601 | ,023868 |
| LVOTi (mm/m2) | 91,70272 | ,000031 |
| LVDVi ml/m2 | 81,35754 | ,001299 |
| RLVWT | 78,80142 | ,109878 |
| LVMi g/m2 | 78,73733 | ,800141 |
| D1 distance | 64,62039 | ,000172 |
| Effort Angina | 52,25502 | ,000438 |
LVOTi; LVDVi; RLVWT; LVMi; D1 – as previously defined